SuperGen, Inc. to Present at the Acumen BioFin Rodman & Renshaw Fourth Annual Global Healthcare Conference

DUBLIN, Calif., May 9 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that Dr. James S. Manuso, President and CEO, will present a corporate overview and highlight SuperGen's recent developments at the Acumen BioFin Rodman & Renshaw Fourth Annual Global Healthcare Conference at 8:40 a.m. CEST on Monday, May 14, 2007, at the La Meridien Beach Plaza Hotel at the Sea Club in Monte Carlo, Monaco.

A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the company's Web site at http://www.supergen.com. The Webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase inhibitors and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.

Contacts: SuperGen Timothy L. Enns Russo Partners, LLC S.V.P., Corporate Communications Greg Geissman & Business Development Director of Media Relations (925) 560-0100 x111 (619) 814-3510 tenns@supergen.comgreg.geissman@russopartnersllc.com

SuperGen, Inc.

CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment of SuperGen +1-925-560-0100 x111, tenns@supergen.com; or GregGeissman Director of Media Relations of Russo Partners, LLC,+1-619-814-3510, greg.geissman@russopartnersllc.com for SuperGen, Inc.

Back to news